23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-22.40%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-22.60%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-8.69%
Negative EBIT growth while Insurance - Life median is -8.69%. Seth Klarman would check if external or internal factors caused the decline.
-8.69%
Negative operating income growth while Insurance - Life median is -8.69%. Seth Klarman would check if structural or cyclical issues are at play.
-19.61%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-19.59%
Negative EPS growth while Insurance - Life median is -10.77%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-19.61%
Negative diluted EPS growth while Insurance - Life median is -12.31%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-72.12%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-72.12%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
124.99%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 112.13%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
85.70%
5Y revenue/share growth 1.25-1.5x Insurance - Life median of 57.93%. Mohnish Pabrai might attribute the outperformance to scale or brand strength.
4.26%
3Y revenue/share growth below 50% of Insurance - Life median of 12.19%. Jim Chanos would suspect a significant short-term erosion in competitiveness.
No Data
No Data available this quarter, please select a different quarter.
-39.24%
Negative 5Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-49.59%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
318.49%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 171.38% over a decade. Joel Greenblatt might see a standout compounder of earnings.
154.49%
5Y net income/share CAGR > 1.5x Insurance - Life median of 86.97%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
7.50%
3Y net income/share CAGR of 7.50% while Insurance - Life median is zero. Walter Schloss might see a small advantage that can be scaled further.
No Data
No Data available this quarter, please select a different quarter.
165.98%
5Y equity/share CAGR > 1.5x Insurance - Life median of 24.84%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
6.32%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.32%
Asset growth of 3.32% while Insurance - Life median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.39%
Positive BV/share change while Insurance - Life median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-52.98%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-2.79%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.